Cargando…
An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y‐27632, a Rho kinase inhibitor
Scar formation is the most common cause for failure of glaucoma filtration surgery because of increased fibroblast proliferation and activation. We have now examined the effect of Y‐27632, a Rho‐associated protein kinase (ROCK) inhibitor, on postsurgical scarring formation in human Tenon fibroblasts...
Autores principales: | Ibrahim, Diah Gemala, Ko, Ji‐Ae, Iwata, Wakana, Okumichi, Hideaki, Kiuchi, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646872/ https://www.ncbi.nlm.nih.gov/pubmed/30773659 http://dx.doi.org/10.1002/cbf.3382 |
Ejemplares similares
-
SPARC is expressed in scars of the Tenon’s capsule and mediates scarring properties of human Tenon’s fibroblasts in vitro
por: Fuchshofer, Rudolf, et al.
Publicado: (2011) -
Effects of the Rho-Kinase Inhibitor Y-27632 on Extraocular Muscle Surgery in Rabbits
por: Moon, Ji‐Sun, et al.
Publicado: (2017) -
Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study
por: Mizuno, Yu, et al.
Publicado: (2022) -
Anti-scarring effects of conbercept on human Tenon’s fibroblasts: comparisons with bevacizumab
por: Zuo, Lei, et al.
Publicado: (2023) -
A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
por: Mizuno, Yu, et al.
Publicado: (2023)